Bionano Genomics, Inc. cotiza a 1.36 USD y tiene una capitalización bursátil de $16M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.64 | $-0.75 | $-0.03 |
| Estimado | $-0.54 | $-0.67 | $-0.95 | $-4.14 |
| Sorpresa | — | +4.5% | +21.1% | +99.3% |
| Métrica | BNGO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 46.3% | 57.0% | -10.8% |
| Operating Margin | -117.0% | -38.6% | -78.3% |
| Net Margin | -92.6% | -33.6% | -59.0% |
| FCF Margin | — | -13.9% | — |
| ROE | -59.4% | -40.4% | -19.0% |
| ROA | -35.9% | -32.0% | -3.9% |
| Current Ratio | 1.98 | 2.84 | -0.86 |
| Debt / Equity | — | 0.28 | — |